Senestech, Inc. (SNES) — 8-K Filings
All 8-K filings from Senestech, Inc.. Browse 20 Current Event Report reports with AI-powered summaries and risk analysis.
8-K Filings (20)
-
SenesTech, Inc. Relocates HQ, Reports Officer Changes
— Nov 14, 2025 Risk: medium
SenesTech, Inc. announced on November 7, 2025, a change in its principal executive offices to 13430 North Dysart Road, Suite 105, Surprise, Arizona 85379. The c -
SenesTech, Inc. Files 8-K: Executive & Director Changes
— Oct 21, 2025 Risk: medium
On October 15, 2025, SenesTech, Inc. filed an 8-K report detailing changes in its executive officers and board of directors. The filing also includes informatio -
SenesTech Files 8-K Report
— Sep 24, 2025 Risk: low
On September 24, 2025, SenesTech, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating upd -
SenesTech Files 8-K on Financials
— Aug 7, 2025 Risk: low
SenesTech, Inc. filed an 8-K on August 7, 2025, reporting on its results of operations and financial condition, and including financial statements and exhibits. -
SenesTech Files 8-K: Material Agreement, Equity Sales
— Aug 5, 2025 Risk: medium
SenesTech, Inc. filed an 8-K on August 5, 2025, reporting on an entry into a material definitive agreement, unregistered sales of equity securities, and Regulat -
SenesTech Appoints New Scientific and Medical Officers
— Jul 10, 2025 Risk: medium
SenesTech, Inc. announced on July 5, 2025, a change in its executive team. The company appointed Dr. Robert L. Smith as Chief Scientific Officer and Dr. David L -
SenesTech, Inc. Files 8-K with Material Agreements
— Jul 1, 2025 Risk: medium
On June 30, 2025, SenesTech, Inc. entered into a Material Definitive Agreement. The company also reported on unregistered sales of equity securities and provide -
SenesTech Files 8-K
— Jun 30, 2025 Risk: low
SenesTech, Inc. filed an 8-K on June 30, 2025, reporting other events and financial statements. The filing does not contain specific financial figures or materi -
SenesTech Reports on Security Holder Vote
— Jun 10, 2025 Risk: medium
SenesTech, Inc. filed an 8-K on June 10, 2025, reporting on a matter submitted to a vote of its security holders on June 9, 2025. The filing does not disclose t -
SenesTech Files 8-K on Financials
— Mar 12, 2025 Risk: low
SenesTech, Inc. filed an 8-K on March 12, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exh -
SenesTech, Inc. Files 8-K with Material Agreement and Equity Disclosures
— Mar 11, 2025 Risk: medium
On March 9, 2025, SenesTech, Inc. entered into a material definitive agreement. The company also disclosed unregistered sales of equity securities and provided -
SenesTech Announces Director Change and Officer Compensation
— Jan 10, 2025 Risk: medium
SenesTech, Inc. announced on January 8, 2025, the departure of director Dr. Robert L. Smith and the appointment of Dr. David E. Miller as a new director. The co -
SenesTech Files 8-K for Operations and Financials
— Nov 12, 2024 Risk: low
SenesTech, Inc. filed an 8-K on November 12, 2024, to report on its results of operations and financial condition, as well as to file financial statements and e -
SenesTech Files 8-K: Material Agreement, Equity Sales
— Aug 23, 2024 Risk: medium
On August 22, 2024, SenesTech, Inc. entered into a Material Definitive Agreement, the details of which are not fully disclosed in this filing. The company also -
SenesTech Faces Delisting Concerns
— Aug 5, 2024 Risk: high
SenesTech, Inc. filed an 8-K on July 31, 2024, to report a notice of delisting or failure to satisfy a continued listing rule or standard. The company, incorpor -
SenesTech Files 8-K for Bylaws, Reg FD, and Financials
— Jul 23, 2024 Risk: low
SenesTech, Inc. filed an 8-K on July 23, 2024, to report amendments to its Articles of Incorporation or Bylaws, a Regulation FD disclosure, and financial statem -
SenesTech Appoints New Chief Scientific Officer
— Jul 15, 2024 Risk: low
SenesTech, Inc. announced on July 11, 2024, the appointment of Dr. Robert L. Smith as Chief Scientific Officer. Dr. Smith brings extensive experience in pest ma -
SenesTech Files Material Definitive Agreement 8-K
— Jun 20, 2024 Risk: medium
On June 20, 2024, SenesTech, Inc. filed an 8-K report detailing a material definitive agreement. The filing does not disclose specific details of the agreement, -
SenesTech Files 8-K on Shareholder Nominations
— May 1, 2024 Risk: medium
SenesTech, Inc. filed an 8-K on May 1, 2024, to report shareholder nominations for its board of directors. This filing is in accordance with Exchange Act Rule 1 -
SenesTech Receives Delisting Notice, Faces Listing Compliance Issues
— Feb 27, 2024 Risk: high
SenesTech, Inc. filed an 8-K on February 27, 2024, to report a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard, along with a Tran
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX